The contribution of the ABCG2 C421A polymorphism to cancer susceptibility: a meta-analysis of the current literature
Open Access
- 1 September 2012
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 12 (1) , 383
Abstract
Background: ABCG2, also known as BCRP, is a half ATP-binding cassette (ABC) transporter that localizes to plasma membranes. Recently, a number of studies have investigated the relationship between the C421A polymorphism in ABCG2 and cancer risk in multiple populations and various types of cancers; however, this relationship remains unclear. Therefore, we performed a meta-analysis to further explore this association. Methods: The meta-analysis incorporated 10 studies involving a total of 3593 cases and 5875 controls. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated based on the date extracted from the studies to evaluate the strength of association. We also analyzed the heterogeneity and sensitivity of each report and the publication bias of the studies. Results: Overall, our results showed that there appeared to be a significant association between the ABCG2 C421A polymorphism and decreased cancer susceptibility (heterozygote-AC versus CC: OR = 0.759, 95%CI = 0.620-0.930; dominant effects model-AA/AC versus CC: OR = 0.771, 95%CI = 0.634-0.938; additive effects model-A allele versus C allele: OR = 0.809, 95%CI = 0.687-0.952). Similarly, decreased cancer risk was also found after stratification of the SNP data by cancer type, ethnicity and source of controls in heterozygote model, dominant effects model and additive effects model. Conclusions: We found that the ABCG2 C421A polymorphism is a protective factor for developing cancer. The same relationship was found when the studies were stratified by cancer type, ethnicity and source of controls.Keywords
This publication has 40 references indexed in Scilit:
- Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLLBlood, 2011
- Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32Nature Genetics, 2010
- Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort studyBMC Cancer, 2009
- Association of the ABCG2 C421A polymorphism with prostate cancer risk and survivalBJU International, 2008
- A gene-wide investigation on polymorphisms in the ABCG2/BRCP transporter and susceptibility to colorectal cancerMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2008
- Association of the BCRP C421A polymorphism with nonpapillary renal cell carcinomaInternational Journal of Cancer, 2005
- Association studies for finding cancer-susceptibility genetic variantsNature Reviews Cancer, 2004
- ABCG2 – a transporter for all seasonsFEBS Letters, 2004
- Nestin-positive progenitor cells derived from adult human pancreatic islets of Langerhans contain side population (SP) cells defined by expression of the ABCG2 (BCRP1) ATP-binding cassette transporterBiochemical and Biophysical Research Communications, 2002
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986